SynthesisFrontiers in immunology2022

Chimeric Antigen Receptor (CAR)-T Cell Immunotherapy Against Thoracic Malignancies: Challenges and Opportunities.

Long Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.